A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Background: Recent studies have reported findings regarding the addition of pegylated interferon aligned -alpha (Peg- IFNα) to nucleos (t) analog ideas. This study was designed to compare the efficacy of Peg- IFNα therapy and tenofovir disoproxil fumarate (TDF) in combination with each treatment separately.


Methods: In this open-label, randomized clinical trial, treatment-naive hepatitis B e antigen (HBeAg) -negative patients were randomly assigned to three treatment groups: Group A: Peg- IFNα (180 mcg / week) with TDF (300 mg / day); Group B: TDF (300 mg / day); and Group C: Peg- IFNα (180 mcg / week). intervention runs 48 weeks and patients were followed every 12 weeks. Primary endpoint was the burden of HBV DNA <20 IU / mL.


Results: Group A, B and C, each consisting of 22, 23 and 22 patients, respectively. The number of patients with HBV DNA suppression in group A was significantly higher than in group B and C (P = 0.034). No significant differences were observed in the trend of normalization of serum ALT levels between the three groups (P = 0.082). At week 48, the combination therapy was significantly more effective in suppressing HBV DNA concentrations below detection levels of TDF monotherapy (OR = 2.1, 95% CI: 1.18 to 4.15; P = 0.034). In addition, the comparison between the monotherapy arm revealed that both interventions have the same effect on the overall outcome (OR = 1.24, 95% CI: 1.02 to 5.8; P = 0.062).


Conclusion: A Peg- IFNα and TDF combination therapy resulted in a good and safe virologic response in patients with HBeAg negative. Monotherapy with Peg-IFNα or TDF benefit was limited compared.

 A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study
A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Double-blind, randomized trial to compare the efficacy of escitalopram compared to citalopram for depression induced interferon in patients with hepatitis C

Objective: The objective of this study was to compare two antidepressant drug citalopram and escitalopram on the basis of success in depressed patients of hepatitis C patients who received interferon.


Methods: In a double-blind randomized trial, patients with hepatitis C visit the National institute liver and gastro intestinal diseases (NILGID), Dow University Hospital, screened for depression before starting treatment with interferon. Institutional review board approval was obtained and references no.is mail: IRB-682 / DUHS / approval / 2016/169. Patients with a history of depression were excluded from the study. The patients who started therapy with interferon assessed for depression at baseline and then at each visit. Those who develop depression were randomly assigned to receive either citalopram or escitalopram. treatment groups was assessed by a scale of depression every time they visit the clinic. Two antidepressants compared to their success in an interval of 4 weeks, 8weeks and then 12 weeks.

IFNA16 Antibody

1-CSB-PA011036LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

IFNA16 siRNA

20-abx920220
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol
  • Shipped within 5-10 working days.

anti-IFNA16

YF-PA12588 50 ug
EUR 363
Description: Mouse polyclonal to IFNA16

anti-IFNA16

YF-PA12589 100 ug
EUR 403
Description: Rabbit polyclonal to IFNA16

IFNA16 Conjugated Antibody

C37641 100ul
EUR 397

IFNA16 ORF Vector (Human) (pORF)

ORF021358 1.0 ug DNA Ask for price

IFNA16 Antibody, HRP conjugated

1-CSB-PA011036LB01HU
  • EUR 317.00
  • EUR 335.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

IFNA16 Antibody, FITC conjugated

1-CSB-PA011036LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

IFNA16 Antibody, Biotin conjugated

1-CSB-PA011036LD01HU
  • EUR 317.00
  • EUR 335.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Human IFNA16 shRNA Plasmid

20-abx952338
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

IFNA16 Protein Vector (Human) (pPB-C-His)

PV085429 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPB-N-His)

PV085430 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPM-C-HA)

PV085431 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPM-C-His)

PV085432 500 ng Ask for price

Interferon Alpha 16 (IFNA16) Antibody

20-abx211357
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Recombinant Interferon Alpha 16 (IFNa16)

4-RPG968Mu01
  • EUR 530.08
  • EUR 245.00
  • EUR 1712.80
  • EUR 637.60
  • EUR 1175.20
  • EUR 418.00
  • EUR 4132.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Q810G1
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 49kDa
  • Isoelectric Point: 9.6
Description: Recombinant Mouse Interferon Alpha 16 expressed in: E.coli

IFNA16 sgRNA CRISPR Lentivector set (Human)

K1020001 3 x 1.0 ug
EUR 339

Human Interferon Alpha 16 (IFNa16) Protein (Active)

20-abx655681
  • EUR 1121.00
  • EUR 411.00
  • EUR 3724.00
  • EUR 1358.00
  • EUR 759.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-15 working days.

Human Interferon alpha- 16, IFNA16 ELISA KIT

ELI-48218h 96 Tests
EUR 824

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 1)

K1020002 1.0 ug DNA
EUR 154

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 2)

K1020003 1.0 ug DNA
EUR 154

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 3)

K1020004 1.0 ug DNA
EUR 154

Human Interferon Alpha 16(IFNa16)ELISA Kit

QY-E03458 96T
EUR 361

IFNA16 3'UTR GFP Stable Cell Line

TU060478 1.0 ml
EUR 1394

IFNA16 3'UTR Luciferase Stable Cell Line

TU010478 1.0 ml
EUR 1394

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K1020005 3 x 1.0 ug
EUR 376

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K1020006 1.0 ug DNA
EUR 167

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K1020007 1.0 ug DNA
EUR 167

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K1020008 1.0 ug DNA
EUR 167

dCas9-KRAB Lentiviral Vector

K203 10 ug
EUR 228

Cas9 Nuclease Lentiviral Vector

K002 10 ug
EUR 154

Cas9 Nickase Lentiviral Vector

K005 10 ug
EUR 154

pSMPUW-MNDnLacZ Lentiviral Control Vector

LTV-402 10 µg
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pLenti-GFP Lentiviral Control Vector

LTV-400 100 µL
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-Puro Lentiviral Expression Vector

VPK-212 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Neo Lentiviral Expression Vector

VPK-213 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Hygro Lentiviral Expression Vector

VPK-214 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pLenti-RFP-Puro Lentiviral Control Vector

LTV-403 100 µL
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-GFP-LC3 Lentiviral Expression Vector

LTV-801 10 µg
EUR 1204
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included.

ESR1 Lentiviral Vector (Human) (pLenti-II)

LV010008 1.0 ug DNA
EUR 316

pSMPUW-GFP-Puro Lentiviral Control Vector

LTV-401 10 µg
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW Universal Lentiviral Expression Vector (Promoterless)

VPK-211 10 µg
EUR 624
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Puro Lentiviral Expression Vector

VPK-215 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Neo Lentiviral Expression Vector

VPK-216 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Hygro Lentiviral Expression Vector

VPK-217 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Blasticidin Lentiviral Expression Vector

VPK-219 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

DPY19L1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723333 1.0 ug DNA Ask for price

DPY19L1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723334 1.0 ug DNA Ask for price

DRD5P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723353 1.0 ug DNA Ask for price

DRD5P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723357 1.0 ug DNA Ask for price

DRD5P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723358 1.0 ug DNA Ask for price

DRD5P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723359 1.0 ug DNA Ask for price

DRD5P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723363 1.0 ug DNA Ask for price

DRD5P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723364 1.0 ug DNA Ask for price

DSTNP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723383 1.0 ug DNA Ask for price

DSTNP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723387 1.0 ug DNA Ask for price

DSTNP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723388 1.0 ug DNA Ask for price

DSTNP3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723389 1.0 ug DNA Ask for price

DSTNP3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723393 1.0 ug DNA Ask for price

DSTNP3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723394 1.0 ug DNA Ask for price

DTX2P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723395 1.0 ug DNA Ask for price

DTX2P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723399 1.0 ug DNA Ask for price

DTX2P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723400 1.0 ug DNA Ask for price

DURS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723401 1.0 ug DNA Ask for price

DURS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723405 1.0 ug DNA Ask for price

DURS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723406 1.0 ug DNA Ask for price

DUSPP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723407 1.0 ug DNA Ask for price

DUSPP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723411 1.0 ug DNA Ask for price

DUSPP Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723412 1.0 ug DNA Ask for price

DUTP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723413 1.0 ug DNA Ask for price

DUTP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723417 1.0 ug DNA Ask for price

DUTP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723418 1.0 ug DNA Ask for price

DUTP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723419 1.0 ug DNA Ask for price

DUTP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723423 1.0 ug DNA Ask for price

DUTP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723424 1.0 ug DNA Ask for price

DUTP4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723425 1.0 ug DNA Ask for price

DUTP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723429 1.0 ug DNA Ask for price

DUTP4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723430 1.0 ug DNA Ask for price

DUTP5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723431 1.0 ug DNA Ask for price

DUTP5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723435 1.0 ug DNA Ask for price

DUTP5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723436 1.0 ug DNA Ask for price

DUTP6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723437 1.0 ug DNA Ask for price

DUTP6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723441 1.0 ug DNA Ask for price

DUTP6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723442 1.0 ug DNA Ask for price

DUTP7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723443 1.0 ug DNA Ask for price

DUTP7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723447 1.0 ug DNA Ask for price

DUTP7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723448 1.0 ug DNA Ask for price

DUTP8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723449 1.0 ug DNA Ask for price

DUTP8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723453 1.0 ug DNA Ask for price

DUTP8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723454 1.0 ug DNA Ask for price

DUX4L8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723455 1.0 ug DNA Ask for price

DUX4L8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723459 1.0 ug DNA Ask for price

DUX4L8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723460 1.0 ug DNA Ask for price

DUX4L10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723461 1.0 ug DNA Ask for price

DUX4L10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723465 1.0 ug DNA Ask for price

DUX4L10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723466 1.0 ug DNA Ask for price

DUX4L11 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723467 1.0 ug DNA Ask for price

DUX4L11 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723471 1.0 ug DNA Ask for price

DUX4L11 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723472 1.0 ug DNA Ask for price

DUX4L14 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723473 1.0 ug DNA Ask for price

DUX4L14 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723477 1.0 ug DNA Ask for price

DUX4L14 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723478 1.0 ug DNA Ask for price

DUX4L16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723479 1.0 ug DNA Ask for price

DUX4L16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723483 1.0 ug DNA Ask for price

DUX4L16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723484 1.0 ug DNA Ask for price

DUX4L17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723485 1.0 ug DNA Ask for price

DUX4L17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723489 1.0 ug DNA Ask for price

DUX4L17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723490 1.0 ug DNA Ask for price

DUX4L18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723491 1.0 ug DNA Ask for price

DUX4L18 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723495 1.0 ug DNA Ask for price

DUX4L18 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723496 1.0 ug DNA Ask for price

DUX4L19 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723497 1.0 ug DNA Ask for price

DUX4L19 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723501 1.0 ug DNA Ask for price

DUX4L19 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723502 1.0 ug DNA Ask for price

DUXB Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723503 1.0 ug DNA Ask for price

DUXB Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723507 1.0 ug DNA Ask for price

DUXB Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723508 1.0 ug DNA Ask for price

DVL1L1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723509 1.0 ug DNA Ask for price

DVL1L1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723513 1.0 ug DNA Ask for price

DVL1L1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723514 1.0 ug DNA Ask for price

DWS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723515 1.0 ug DNA Ask for price

DWS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723519 1.0 ug DNA Ask for price

DWS Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723520 1.0 ug DNA Ask for price

DYNLL1P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723521 1.0 ug DNA Ask for price

DYNLL1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723525 1.0 ug DNA Ask for price

DYNLL1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723526 1.0 ug DNA Ask for price

DYRK1AIP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723527 1.0 ug DNA Ask for price

DYRK1AIP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723531 1.0 ug DNA Ask for price

DYRK1AIP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723532 1.0 ug DNA Ask for price

DYRK1AIP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723533 1.0 ug DNA Ask for price

DYRK1AIP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723537 1.0 ug DNA Ask for price

DYRK1AIP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723538 1.0 ug DNA Ask for price

DYT2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723539 1.0 ug DNA Ask for price

DYT2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723543 1.0 ug DNA Ask for price

DYT2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723544 1.0 ug DNA Ask for price

DYT4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723545 1.0 ug DNA Ask for price

DYT4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723549 1.0 ug DNA Ask for price

DYT4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723550 1.0 ug DNA Ask for price

DYT7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723551 1.0 ug DNA Ask for price

DYT7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723555 1.0 ug DNA Ask for price

DYT7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723556 1.0 ug DNA Ask for price

DYT10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723557 1.0 ug DNA Ask for price

DYT10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723561 1.0 ug DNA Ask for price

DYT10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723562 1.0 ug DNA Ask for price

DYT13 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723563 1.0 ug DNA Ask for price

DYT13 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723567 1.0 ug DNA Ask for price

DYT13 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723568 1.0 ug DNA Ask for price

DYT15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723569 1.0 ug DNA Ask for price

DYT15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723573 1.0 ug DNA Ask for price

DYT15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723574 1.0 ug DNA Ask for price

DYT17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723575 1.0 ug DNA Ask for price

DYT17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723579 1.0 ug DNA Ask for price

DYT17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723580 1.0 ug DNA Ask for price

DYT21 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723581 1.0 ug DNA Ask for price

DYT21 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723585 1.0 ug DNA Ask for price

DYT21 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723586 1.0 ug DNA Ask for price

DYT22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723587 1.0 ug DNA Ask for price

DYT22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723591 1.0 ug DNA Ask for price

DYT22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723592 1.0 ug DNA Ask for price

DYX1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723593 1.0 ug DNA Ask for price

DYX1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723597 1.0 ug DNA Ask for price

DYX1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723598 1.0 ug DNA Ask for price

DYX2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723605 1.0 ug DNA Ask for price

DYX2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723609 1.0 ug DNA Ask for price

DYX2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723610 1.0 ug DNA Ask for price

DYX3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723611 1.0 ug DNA Ask for price

DYX3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723615 1.0 ug DNA Ask for price

DYX3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723616 1.0 ug DNA Ask for price

DYX4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723617 1.0 ug DNA Ask for price

DYX4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723621 1.0 ug DNA Ask for price

DYX4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723622 1.0 ug DNA Ask for price

DYX5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723623 1.0 ug DNA Ask for price

DYX5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723627 1.0 ug DNA Ask for price

DYX5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723628 1.0 ug DNA Ask for price

DYX6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723629 1.0 ug DNA Ask for price

DYX6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723633 1.0 ug DNA Ask for price

DYX6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723634 1.0 ug DNA Ask for price

DYX7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723635 1.0 ug DNA Ask for price

DYX7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723639 1.0 ug DNA Ask for price

DYX7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723640 1.0 ug DNA Ask for price

DYX8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723641 1.0 ug DNA Ask for price

DYX8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723645 1.0 ug DNA Ask for price

DYX8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723646 1.0 ug DNA Ask for price

DYX9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723647 1.0 ug DNA Ask for price

DYX9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723651 1.0 ug DNA Ask for price

DYX9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723652 1.0 ug DNA Ask for price

E2F3P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723659 1.0 ug DNA Ask for price

E2F3P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723663 1.0 ug DNA Ask for price

E2F3P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723664 1.0 ug DNA Ask for price

E2F4P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723665 1.0 ug DNA Ask for price


Results: In the present study 80 patients were randomized to receive either citalopram or escitalopram. The research result was better in patients treated with escitalopram. Significant changes in depression scores from the beginning to the end of the study was greater in the escitalopram group is 10.41 compared with citalopram group is 14.17. Differences in depression scores were also calculated as 4.28 and.3.76 (p <0.001) for both drugs at week 8 and week 12 respectively, which were statistically significant. Difference in depression scores were also calculated for the sex of 0.576 (p = 0.497) and age of 0.950 (p = 0.265), were found to be significant, statistically.


Conclusion: The results show the superiority of escitalopram over citalopram, the drug is twice as potent as racemic mixtures. In addition the drug is well tolerated and showed a better effect. Escitalopram proven to be a safer alternative to citalopram.